Advertisement

Stimulant Medications and the Treatment of Children with ADHD

  • James M. Swanson
  • Keith McBurnett
  • Diane L. Christian
  • Tim Wigal
Chapter
Part of the Advances in Clinical Child Psychology book series (ACCP, volume 17)

Abstract

Stimulant medications have been used for over 55 years to treat children affected by a condition once called hyperactivity and now termed attention deficit disorder (ADD) (DSM-III, 1980) or attention-deficit hyperactivity disorder (ADHD) (DSM-III-R, 1987; DSM-IV, 1994). In this chapter, we will use the term currently en vogue (ADHD) to refer to all of the conditions (e.g., minimal brain damage, minimal brain dysfunction, hyperactivity, hyper-kinesis, attention deficit disorder) which over the years have shared some or all of the basic symptoms of this disorder (i.e., inattention, impulsivity, and hyperactivity).

Keywords

Stimulant Medication Learn Disability ADHD Child Attention Deficit Disorder Stimulant Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Appendix B Table B.1 1900–1949

  1. 1.
    Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577–585.... 72Google Scholar
  2. 20.
    Strauss, A. A., & Lehtinen, L. E. (1947). Psychopathology and education of the brain-injured child. New York: Grune & Stratton.... 29Google Scholar
  3. Bradley, C., & Bowen, M. (1940). School performance of children receiving amphetamine (benzedrine) sulfate. American Journal of Orthopsychiatry, 10, 782–788.... 13CrossRefGoogle Scholar
  4. Kahn, E., & Cohen, L. H. (1934). Organic driveness: A brain stem syndrome and an experience. With case reports. New England Journal of Medicine, 210, 748–756... 12CrossRefGoogle Scholar
  5. Bradley, C., & Bowen, M. (1941). Amphetamine (benzedrine) therapy of children’s behavior disorders. American Journal of Orthopsychiatry, 11, 92–103.... 12CrossRefGoogle Scholar
  6. Still, G. G. (1902). The Coulstonian Lectures on some abnormal psychical conditions in children. Lancet, 1, 1008–1012, 1077–1082, 1163–1168.... 10Google Scholar
  7. Hohman, L. B. (1922). Post-enciphalitic behavior disorders in children. Johns Hopkins Hospital Bulletin, 380, 372–375.... 10Google Scholar
  8. Bender, L., & Cottington, F. (1943). The use of amphetamine sulfate (benzedrine) in child psychiatry. American Journal of Psychiatry, 99, 116–121....9Google Scholar
  9. Molitch, M, & Eccles, A. (1937). Effects of benzedrine sulfate on the intelligence scores of children. American Journal of Psychiatry, 94, 587–590.... 8Google Scholar
  10. Lindsley, D., & Henry, C. (1942). The effect of drugs on behavior and the electroencephalogram of children with behavior disorders. Psychosomatic Medicine, 4, 140–149.... 7Google Scholar
  11. Molitch, M., & Sullivan, J. P. (1937). Effect of benzedrine sulfate on children taking new Stanford achievement test. American Journal of Orthopsychiatry, 7, 519.... 6CrossRefGoogle Scholar
  12. Bradley, C., & Green, E. (1940). Psychometric performances of children receiving amphetamine (benzedrine) sulfate. American Journal of Psychiatry, 97, 388–394.... 6Google Scholar
  13. Cutler, M., Little, J. W., & Strauss, A. A. (1940). The effect of Benzedrine on mentally deficient children. American Journal of Mental Deficiency, 45, 59–65....5Google Scholar
  14. Werner, H., & Strauss, A. A. (1941). Pathology of figure-background relation in the child. Journal of Abnormal Social Psychology, 36, 236–248.... 4CrossRefGoogle Scholar
  15. Orton, S. T. (1937). Reading, writing and speech problems in children. New York: Norton.... 4Google Scholar
  16. Hollingworth, H. L. (1912). The influence of caffeine on mental and motor efficiency. Archives of Psychology, 3, 1–166.... 4Google Scholar
  17. Ebaugh, F. G. (1923). Neuropsychiatric sequelae of acute epidemic encephalitis in children. American Journal of Dis Child, 25, 89–97.... 4Google Scholar
  18. Bender, L. (1949). Psychological problems of children with organic brain disease. American Journal of Orthopsychiatry, 19, 404–441.... 4PubMedCrossRefGoogle Scholar
  19. Sherrington, C. (1906). The integrative action of the nervous system. New Haven, CT: Yale University Press.... 3Google Scholar
  20. Kraepelin, E. (1921). Manic-depressive insanity and paranoia. Edinburgh: E. & S. Livingstone.... 3Google Scholar
  21. Korey, S. (1944). The effects of benzedrine sulfate on the behavior of psychopathic and neurotic juvenile delinquents. Psychiatry, 18, 127–137.... 3Google Scholar
  22. Gesell, A., & Amatruda, C. S. (1947). Developmental diagnosis. New York: Paul B. Hoeber.... 3Google Scholar
  23. Dreisbach, R. H., & Pfeiffer, C. (1943). Caffeine-withdrawal headache. Journal of Laboratory and Clinical Medicine, 28, 1212.... 3Google Scholar
  24. Bond, E. D., & Smith, L. H. (1935). Post-encephalitic behavior disorders. American Journal of Psychiatry, 92, 17....3Google Scholar
  25. Bond, E. (1932). Postencephalitic, ordinary and extraordinary children. Journal of Pediatrics, 1, 310–314.... 3CrossRefGoogle Scholar
  26. Bender, L. (1942). Postencephalitic behavior disorders in children. In J. Neil (Ed.), Encephalitis: A clinical study. New York: Grune & Stratton....3Google Scholar

Table B.2 1950–1959

  1. 18.
    Laufer, M. W., Denhoff, E., & Solomons, G. (1957). Hyperkinetic impulse disorders in children’s behavior problems. Psychosomatic Medicine, 19, 38–49....33PubMedGoogle Scholar
  2. 25T.
    Bradley, C. (1950). Benzedrine and dexedrine in the treatment of children’s behavior disorders. Pediatrics, 5, 24–37.... 27PubMedGoogle Scholar
  3. Laufer, M. W., & Denhoff, E. (1957). Hyperactive behavior syndrome in children. Journal of Pediatrics, 50, 463–474.... 25PubMedCrossRefGoogle Scholar
  4. Rosvold, E., Mirsky, R., Sarason, I., Bransome, E., & Beck, L. (1956). A continuous performance test of brain damage. Journal of Counseling Psychology, 20, 343–350.... 13Google Scholar
  5. Strauss, A. A., & Kephart, N. C. (1955). Psychopathology and education of the brain-injured child: Progress in theory and clinic. New York: Grune & Stratton.... 10Google Scholar
  6. Lytton, G., & Knobel, M. (1958). Diagnosis and treatment of behavior disorders in children. Diseases of the Nervous System, 20, 1–7 or 334–340.... 10Google Scholar
  7. Ounsted, C. (1955). The hyperkinetic syndrome in epileptic children. Lancet, 2, 303–311.... 9CrossRefGoogle Scholar
  8. Pasamanick, B. (1951). Anticonvulsant drug therapy of behavior problem children with abnormal EEG. Archives of Neurology and Psychiatry, 65, 752–766.... 8PubMedCrossRefGoogle Scholar
  9. Knobel, M., Wolman, M B., & Mason, E. (1959). Hyperkinesis and organicity in children. Archives of General Psychiatry, 1, 310–321.... 6PubMedCrossRefGoogle Scholar
  10. Bradley, C. (1957). Characteristics and management of children with behavior problems associated with organic brain damage. Pediatric Clinics of North America, 4, 1049– 1060.... 6Google Scholar
  11. Schulman, J. L., & Reisman, J. M. (1959). An objective measure of hyperactivity. American Journal of Mental Deficiency, 64, 455.... 5PubMedGoogle Scholar
  12. Lapouse, R., & Monk, M. (1958). An epidemiologic study of behavior characteristics in children. American Journal of Public Health, 48, 1134–1144.... 5PubMedCrossRefGoogle Scholar
  13. Freedman, A. M., Effron, A. S., & Bender, L. (1955). Pharmacology in children with psychiatric illness. Journal of Nervous and Mental Disease, 122, 479–486.... 5PubMedCrossRefGoogle Scholar
  14. Davis, G. (1957). Effects of central exitant and depressant drugs on locomotor activity in the monkey. American Journal of Physiology, 188, 619–623.... 5PubMedGoogle Scholar
  15. Oettinger, L. (1958). The use of deanol in the treatment of disorders of behavior in children. Journal of Pediatrics, 53, 671–675.... 4PubMedCrossRefGoogle Scholar
  16. Morris, J. V., MacGillivray, R. C., & Mathieson, C. M. (1955). The results of the experimental administration of amphetamine sulfate, in oligophrenia. Journal of Mental Science/British Journal of Psychiatry, 101, 131–140.... 4CrossRefGoogle Scholar
  17. Mackworth, N. H. (1950). Researches on the measurement of human performance. London: His Majesty’s Stationary Office.... 4Google Scholar
  18. Hunt, B. R., Frank, T., & Krush, T. P. (1956). Chlorpromazine in the treatment of severe emotional disorders of children. American Journal of Diseases of Children, 86, 268–277.... 4Google Scholar
  19. Freed, H, & Peifer, C.(1956). Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chloropromazine. American Journal of Psychiatry, 113, 22–26.... 4PubMedGoogle Scholar
  20. Connell, P. H. (1958). Amphetamine psychosis. London: Chapman & Hall.... 4Google Scholar

Table B.3 1960–1969

  1. 6.
    Conners, C. K. (1969). A teacher rating scale for use in drug studies with children. American Journal of Psychiatry, 126, 884–888.... 50PubMedGoogle Scholar
  2. 17.
    Knights, R. M., & Hinton, G. G. (1969). The effects of methylphenidate (Ritalin) on the motor skills and behavior of children with learning problems. Journal of Nervous and Mental Disease, 148, 643–653.... 34PubMedCrossRefGoogle Scholar
  3. Eisenberg, L., Lachman, R., Moiling, P. A., Lockner, A., Mizelle, J. D., & Conners, C. K. (1963). A psychopharmacologic experiment in a training school for delinquent boys: Methods, problems, findings. American Journal of Orthopsychiatry, 33, 431–446.... 25CrossRefGoogle Scholar
  4. Conners, C., Eisenberg, L., & Barcai, A. (1967). Effects of dextroamphetamine on children: Studies on subjects with learning disabilities and school behavior problems. Archives of General Psychiatry, 17, 478–485.... 25PubMedCrossRefGoogle Scholar
  5. Werry, J. S., Weiss, G., Douglas, V. I., & Martin, J. (1966). Studies on the hyperactive child. Ill: The effect of chlorpromazine upon behavior and learning ability. Journal of the American Academy of Child Psychiatry, 5, 292–312.... 24PubMedCrossRefGoogle Scholar
  6. Conners, C. K., & Rothschild, G. H. (1968). Drugs and learning in children. In J. Hellmuth (Ed.), Learning disorders (pp. 191–223). Seattle: Special Child Publication.... 22Google Scholar
  7. Conners, C. K., Rothschild, G., Eisenberg, L., Schwartz, L. S., & Robinson, E. (1969). Dextroamphetamine sulfate in children with learning disorders: Effects on perception, learning, and achievement. Archives of General Psychiatry, 21, 182–190.... 22PubMedCrossRefGoogle Scholar
  8. Stewart, M. A., Pitts, F. N., Craig, A. G., & Dierof, W. (1966). The hyperactive child syndrome. American Journal of Orthopsychiatry, 36, 861–367.... 21PubMedCrossRefGoogle Scholar
  9. Millichap, J., & Fowler, G. W. (1967). Treatment of minimal brain dysfunction syndromes. Pediatric Clinics of North America, 14, 767–778.... 21PubMedGoogle Scholar
  10. Epstein, L. C., Lasagna, L., Conners, C., & Rodriguez, A. (1968). Correlation of dextroamphetamine excretion and drug response in hyperkinetic children. Journal of Nervous and Mental Diseases, 146, 136–146.... 21CrossRefGoogle Scholar
  11. Conners, C. K., & Eisenberg, L. (1963). The effects of methylphenidate on symptomatology and learning in disturbed children. American Journal of Psychiatry, 120, 458–464.... 21PubMedGoogle Scholar
  12. Conners, C. K., Eisenberg, L., & Sharpe, L. (1964). Effects of methylphenidate (Ritalin) on paired associate learning and Porteus Maze performance in emotionally disturbed children. Journal of Consulting Psychology, 28, 14–22.... 21PubMedCrossRefGoogle Scholar
  13. Weiss, B., & Laties, V. G. (1962). Enhancement of human performance by caffeine and the amphetamines. Psychological Review, 14, 1–36.... 20Google Scholar
  14. Weiss, G., Werry, J. S., Minde, K., Douglas, V. I., & Sykes, D. (1968). Studies on the hyperactive child V: The effects of dextroamphetamine and chlorpromazine on behavior and intellectual functioning. Journal of Child Psychology and Psychiatry, 9, 145–156.... 19PubMedCrossRefGoogle Scholar
  15. Menkes, M. M., Rowe, J.S., & Menkes, J. H. (1967). A 25-year follow-up study on the hyperkinetic child with minimal brain dysfunction. Pediatrics, 39, 393–399.... 19PubMedGoogle Scholar
  16. Clements, S. E., & Peters, J. E. (1962). Minimal brain dysfunction in the school-age child: Diagnosis and treatment. Archives of General Psychiatry, 6, 185–197.... 19PubMedCrossRefGoogle Scholar
  17. Werry, J. (1968). Studies on the hyperactive child. IV. An empirical analysis of the minimal brain dysfunction syndrome. Archives of General Psychiatry, 19, 9–16.... 17PubMedCrossRefGoogle Scholar
  18. Knobel, M. (1962). Psychopharmacology for the hyperkinetic child-dynamic considerations. Archives of General Psychiatry, 6, 30–34.... 17CrossRefGoogle Scholar
  19. Millichap, J. G., & Boldery, E. E. (1967). Studies in hyperkinetic behavior. II: Laboratory and clinical evaluations of drug treatments. Neurology, 17, 467–471.... 16PubMedCrossRefGoogle Scholar
  20. Conrad, W., & Insel, J. (1967). Anticipating the response to amphetamine therapy in the treatment of hyperkinetic children. Pediatrics, 40, 96–98.... 13Google Scholar
  21. Millichap, J. G., Aymot, F., Sturgis, L. H., Larsen, K. W., & Egan, R. A. (1968). Hyperkinetic behavior and learning disorders. Ill: Battery of neuropsychological test in controlled trial of methylphenidate. American Journal of Diseases in Childhood, 116, 235–244.... 12Google Scholar
  22. Freeman, R. D. (1966). Drug effects on learning in children—A selective review of the past 30 years. Journal of Special Education, 1, 17–44.... 12CrossRefGoogle Scholar
  23. Eisenberg, L. (1966). The management of the hyperkinetic child. Developmental Medicine and Child Neurology, 8, 593–598.... 12PubMedCrossRefGoogle Scholar
  24. Clements, S. D. (1966). Minimal brain dysfunction in children: Terminology and identification. In U.S. Department of Health, Education, and Welfare, Public Health Service Publication.... 12Google Scholar

Table B.4 1970–1979

  1. 2.
    Sprague, R. L., & Sleator, E. K. (1977b). Methylphenidate in hyperkinetic children: Difference in dose effects on learning and social behavior. Science, 198, 1274–1276.... 65PubMedCrossRefGoogle Scholar
  2. 4.
    Barkley, R. A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18, 137–165.... 56PubMedCrossRefGoogle Scholar
  3. 5.
    Wender, P. H. (1971). Minimal brain dysfunction in children. New York: Wiley-Inter-science.... 54Google Scholar
  4. 7.
    Weiss, G., Kruger, E., Danielson, V., & Elman, M. (1975). Effect of long-term treatment of hyperactive children with methylphenidate. Canadian Medical Association Journal, 112, 159–165.... 41PubMedGoogle Scholar
  5. 8.
    Sprague, R. L., Barnes, K. R., & Werry, J. S. (1970). Methylphenidate and thioridazine: Learning, reaction time, activity, and classroom behavior in disturbed children. American Journal of Orthopsychiatry, 40, 615–628.... 40PubMedCrossRefGoogle Scholar
  6. 9.
    Rapoport, J., Quinn, P., Bradbard, G., Riddle, D., & Brooks, F. (1974). Imipramine and methylphenidate: Treatments of hyperactive boys. Archives of General Psychiatry, 30, 789–793.... 40PubMedCrossRefGoogle Scholar
  7. 11.
    Douglas, V. I. (1972). Stop, look, and listen: The problem of sustained attention and impulse control in hyperactive and normal children. Canadian Journal of Behavioral Science, 4, 259–282..... 37CrossRefGoogle Scholar
  8. 12.
    Weiss, G., Minde, K., Werry, J. S., Douglas, V. I., & Nemeth, E. (1971). Studies on the hyperactive child. VIII: A five-year follow-up. Archives of General Psychiatry, 24, 409–414.... 36PubMedCrossRefGoogle Scholar
  9. 14.
    Swanson, J., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). A time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21–29.... 34PubMedGoogle Scholar
  10. 15.
    Safer, D. J., Allen, R. P., & Barr, E. (1972). Depression of growth in hyperactive children on stimulant drugs. New England Journal of Medicine, 287 217–220.... 34PubMedCrossRefGoogle Scholar
  11. 16.
    Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Wemgartner, H., Ludlow, C., & Mik-kelsen, I. J. (1978). Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science, 199, 560–563.... 34PubMedCrossRefGoogle Scholar
  12. 19.
    Safer, D. J., & Allen, R. P. (1976). Hyperactive children: Diagnosis and management. Baltimore, MD: University Park Press.... 30Google Scholar
  13. 21.
    Cantwell, D. P., & Carlson, G. A. (1978). Stimulants. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children (pp. 171–217). New York: Brunner/Mazel.... 29Google Scholar
  14. 22.
    Barkley, R. A., & Cunningham, C. E. (1978). Do stimulant drugs improve the academic performance of hyperactive children? A review of outcome research. Clinical Pediatrics, 17, 85–92....29PubMedCrossRefGoogle Scholar
  15. 23.
    Swanson, J. M., & Kinsbourne, M. (1976). Stimulant-related state-dependent learning in hyperactive children. Science, 192, 1354–1356.... 28PubMedCrossRefGoogle Scholar
  16. 24.
    Riddle, K. D., & Rapoport, J. L. (1976). A 2-year follow-up of 72 hyperactive boys: Classroom behavior and peer acceptance. Journal of Nervous and Mental Disease, 162, 126–134.... 28PubMedCrossRefGoogle Scholar
  17. 25T.
    Whalen, C., & Henker, B. (1976). Psychostimulants and children: A review and analysis of drug effectiveness. Psychological Bulletin, 83, 1113–1130.... 27PubMedCrossRefGoogle Scholar
  18. 25T.
    Sprague, R. L., & Werry, J. (1971). Methodology of psychopharmacological studies with the retarded. In N. Ellis (Ed.), International review of research in mental retardation. New York: Academic Press.... 27Google Scholar
  19. 25T.
    Mendelson, W., Johnson, N., & Stewart, M. A. (1971). Hyperactive children as teenagers: A follow-up study. Journal of Nervous and Mental Disease, 153, 273–279.... 27PubMedCrossRefGoogle Scholar
  20. Rie, H. E., Rie, E. D., Stewart, S., & Ambuel, J. P. (1976). Effects of methylphenidate on underachieving children. Journal of Consulting and Clinical Psychology, 44, 250–260.... 26PubMedCrossRefGoogle Scholar
  21. Quinn, P., & Rapoport, J. (1975). One-year follow-up of hyperactive boys treated with imipra-mine and methylphenidate. American Journal of Psychiatry, 132, 241–245.... 25PubMedGoogle Scholar
  22. Gittelman-Klein, R., & Klein, D. (1976). Methylphenidate effects in learning disabilities. Archives of General Psychiatry, 33, 655.... 25CrossRefGoogle Scholar
  23. Schleifer, M., Weiss, G., Cohen, N., Elman, M., Cvejic, H., & Kruger, E. (1975). Hyperactivity in preschoolers and the effect of methylphenidate. American Journal of Orthopsychiatry, 45, 38–50.... 24PubMedCrossRefGoogle Scholar
  24. Werry, J. S., & Sprague, R. L. (1974). Methylphenidate in children: Effect of dosage. Australian and New Zealand Journal of Psychiatry, 8, 9–19.... 23PubMedCrossRefGoogle Scholar
  25. Werry, J., & Aman, M. (1975). Methylphenidate and haloperidol in children: Effects on attention, memory, and activity. Archives of General Psychiatry, 32, 790–795.... 23PubMedCrossRefGoogle Scholar

Table B.5 1980–1989

  1. 3.
    American Psychiatric Association (1980). DSM-III. Washington, DC: American Psychiatric Association.... 59Google Scholar
  2. 10.
    Rapoport, J. L., Buchsbaum, M. S., Weingartner, H., Zahn, T. P., Ludlow, C., & Mikkelsen, E. (1980). Dextroamphetamine: Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry, 37, 933–943.... 38PubMedCrossRefGoogle Scholar
  3. 13.
    American Psychiatric Association. (1987). DSM-III-R. Washington, DC: American Psychiatric Association.... 35Google Scholar
  4. Douglas, V. L, Barr, R. G., O’Neill, M.E., & Britton, B. G. (1986). Short-term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom. Journal of Child Psychology and Psychiatry, 27, 191–211.... 24PubMedGoogle Scholar
  5. Lowe, T. L., Cohen, D. J., Detlor, J., Kremenitzer, M. W., & Shaywitz, B. A. (1982). Stimulant medications precipitate Tourette’s syndrome. Journal of the American Medical Association, 247, 1729–1731.... 22PubMedCrossRefGoogle Scholar
  6. Weiss, G., & Hechtman, L. (1986). Hyperactive children grown up: Empirical findings and theoretical considerations. New York: Guilford.... 21Google Scholar
  7. Ross, D. M., & Ross, S. A. (1982). Hyperactivity: Current issues, research, and theory. New York: Wiley.... 21Google Scholar
  8. Mattes, J. A., & Gittleman, R. (1983). Growth of hyperactive children on maintenance regimen of methylphenidate. Archives of General Psychiatry, 40, 317–321.... 21PubMedCrossRefGoogle Scholar
  9. Barkley, R. A. (1981). Hyperactive children: A handbook of diagnosis and treatment. New York: Guilford Press.... 21Google Scholar
  10. Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. H. (1985). Methylphenidate and children with attention deficit disorder: Dose effects on classroom academic and social behavior. Archives of General Psychiatry, 42, 948–952.... 20PubMedCrossRefGoogle Scholar
  11. Gadow, K. D. (1983). Effects of stimulant drugs on academic performance in hyperactive and learning disabled children. Journal of Learning Disabilities, 16, 290–299.... 20PubMedCrossRefGoogle Scholar
  12. Satterfield, J. H., Satterfield, B. T., & Cantwell, D. P. (1981). Three-year multimodality treatment study of 100 hyperactive boys. Pediatrics, 98, 650–655.... 18CrossRefGoogle Scholar
  13. Satterfield, J., Hoppe, C., & Schell, A. (1982). A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys. American Journal of Psychiatry, 139, 797–798.... 18Google Scholar
  14. Gittelman, R., Mannuzza, S., Shenker, R., & Bonagura, N. (1985). Hyperactive boys almost grown up. Archives of General Psychiatry, 42, 937–947.... 18PubMedCrossRefGoogle Scholar
  15. Abikoff, H., & Gittelman, R. (1985). Hyperactive children treated with stimulants. Is cognitive training a useful adjunct? Archives of General Psychiatry, 42, 953–961.... 18PubMedCrossRefGoogle Scholar
  16. Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256–2258.... 17PubMedCrossRefGoogle Scholar
  17. Loney, J., Kramer, H., & Milich, R. S. (1981). The hyperactive child grows up: Predictors of symptoms, delinquency, and achievement at follow-up. In K. D. Gadow & J. Loney (Eds.), Psychosocial aspects of drug treatment for hyperactivity (pp. 381–415). Boulder, CO: Westview Press.... 17Google Scholar
  18. Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. Journal of the American Academy of Child Psychiatry, 24, 617–629.... 17PubMedCrossRefGoogle Scholar
  19. Garfinkel, B. D., Wender, P. H., & Sloman, L. (1983). Tricyclic antidepressant and methyl-phenidate treatment of attention deficit disorder in children. Journal of the American Academy of Child & Adolescent Psychiatry, 22, 343–348.... 17CrossRefGoogle Scholar
  20. Charles, L., & Schain, R. (1981). A four-year follow-up study of the effects of methylphenidate on the behavior modification in the treatment of kindergarten-aged hyperactive children. Journal of Abnormal Child Psychology, 9, 495–505.... 17PubMedCrossRefGoogle Scholar
  21. Zametkin, A. J., & Rapoport, J. L. (1987). Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? Journal of the American Academy of Child & Adolescent Psychiatry, 26, 676–686.... 16CrossRefGoogle Scholar
  22. Solanto, M. V. (1984). Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: A review and synthesis. Psychological Bulletin, 95, 387–409.... 16PubMedCrossRefGoogle Scholar
  23. Shaywitz, S. E., Hunt, R. D., Jatlow, P., Cohen, D. J., Young, J. G., Pierce, R. N., Anderson, G. M., & Shaywitz, B. A. (1982). Psychopharmacology of attention deficit disorder: Pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate. Pediatrics, 69, 688–694.... 16PubMedGoogle Scholar
  24. Pelham, W., & Bender, M. E. (1982). Peer relationships in hyperactive children: Description and treatment. In K. Gadow & I. Bailer (Eds.), Advances in learning and behavioral disabilities, (pp. 365–436). Greenwich, CT: J AI Press.... 16Google Scholar
  25. Kavale, K. (1982). The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis. Journal of Learning Disabilities, 15, 280–289.... 16PubMedCrossRefGoogle Scholar
  26. Gualtieri, C. T., Wargin, W., Kanoy, R., Patrick, K., Shen, C. D., Youngblood, W., Mueller, R. A., & Breese, G. R. (1982). Clinical studies of methylphenidate serum levels in children and adults. Journal of the American Academy of Child Psychiatry, 21, 19–26.... 16PubMedCrossRefGoogle Scholar

Table B.6 1990–1992

  1. Pelham, W. E., Jr., Greenslade, K. E., Vodde-Hamilton, M, Murphy, D. A., & Greenstein (1990). Relative efficacy of long-acting stimulants on ADHD children: A comparison of standard methylphenidate, Ritalin-SR, Dexedrene Spansule, and Pemoline. Pediatrics, 86, 226–237.... 9PubMedGoogle Scholar
  2. Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford.... 8Google Scholar
  3. Zametkin, A. J., Nordahl, T. E., Gross, M., King, A. C., Semple, W. E., Rumsey, J., Hamburger, S., & Cohen, R. M. (1990). Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine, 323, 1361–1366.... 7PubMedCrossRefGoogle Scholar
  4. Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria I: An 8-year prospective follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 546–557.... 6CrossRefGoogle Scholar
  5. Riddle, M. A., Nelson, J. C., Kleinman, C. S., Rasmusson, A., Leckman, J. F., King, R. A., & Cohen, D. (1991). Sudden death in children receiving Norpramin: A review of three reported cases and summary. Journal of the American Academy of Child & Adolescent Psychiatry, 30, 104–108.... 5CrossRefGoogle Scholar
  6. McClellan, J. M, Rubert, M. P., Reichler, R. J., et al. (1990). Attention deficit disorder in children at risk for anxiety and depression. Journal of the Academy of Child and Adolescent Psychiatry, 29, 534–539.... 5CrossRefGoogle Scholar
  7. Jacobvitz, D., Sroufe, L. A., Stewart, M, & Leffert, N. (1990). Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 677–688.... 5CrossRefGoogle Scholar
  8. Gadow, K. D., Nolan, E. E., Sverd, J., Sprafkin, J., & Paolicelli, L. (1990). Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 710–718.... 5CrossRefGoogle Scholar
  9. Whalen, C. K., Henker, B., & Granger, D. A. (1990). Social judgment processes in hyperactive boys: Effects of methylphenidate and comparisons with normal peers. Journal of Abnormal Child Psychology, 18, 297–316.... 4PubMedCrossRefGoogle Scholar
  10. Swanson, J. M., Cantwell, D., Lerner, M., McBurnett, K., & Hanna, G. (1991). Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities, 24, 219–230.... 4PubMedCrossRefGoogle Scholar
  11. Rapport, M. D., & Kelly, K. L. (1991). Psychostimulant effects on learning and cognitive function: Findings and implications. Clinical Psychology Review, 11, 61–92.... 4CrossRefGoogle Scholar
  12. Pelham, W., Jr., McBurnett, K., Harper, G. W., Milich, R., Murphy, D. A., Clinton, J., & Thiele, C. (1990). Methylphenidate and baseball playing in ADHD children: Who’s on first? Journal of Consulting Clinical Psychology, 58, 130–133.... 4CrossRefGoogle Scholar
  13. Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990). Stimulant drug treatment of hyperactivity: Biochemical correlates. Clinical Pharmacology and Therapeutics, 48, 57–66.... 4PubMedCrossRefGoogle Scholar
  14. Denckla, M. B. (1991). Attention deficit hyperactivity disorder-residual type. Journal of Child Neurology 6, 44–50.... 4CrossRefGoogle Scholar
  15. Biederman, J., Faraone, S. V., Feenan, K., et al. (1990). Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 526–533.... 4CrossRefGoogle Scholar
  16. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics, 86, 184–192.... 4PubMedGoogle Scholar
  17. Strober, M., Morrell, W., Lampert, C., et al. (1990). Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: A naturalistic study. American Journal of Psychiatry, 147, 457–461.... 3PubMedGoogle Scholar
  18. Shaywitz, B. A., & Shaywitz, S. E. (1991 supplement). Comorbidity: A critical issue in attention deficit disorder. The Journal of Child Neurology, 6, S13-S22.... 3Google Scholar
  19. McGee, R., Feehan, M., Williams, S., et al. (1990). DSM-III disorders in a large sample of adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 611–619.... 3CrossRefGoogle Scholar
  20. Kendall, P. C. (1990). Child and adolescent therapy: Cognitive-behavioral procedures. New York: Guilford.... 3Google Scholar
  21. Hynd, G. W., Semrud-Clikeman, M., Lorys, A., et al. (1990). Brain morphology in developmental dyslexia and attention deficit disorder/ hyperactivity. Archives of Neurology, 47, 919–926.... 3PubMedCrossRefGoogle Scholar
  22. Hynd, G. W., Lorys, A. R., Semrud-Clikeman, M., et al. (1991). Attention deficit disorder without hyperactivity: A distinct behavioral and neurocognitive syndrome. Journal of Child Neurology, 6, 37–42.... 3Google Scholar
  23. Dulcan, M. (1990). Using psychostimulants to treat behavior disorders of children and adolescents. Journal of Child & Adolescent Psychopharmacology, 1, 7–20.... 3CrossRefGoogle Scholar
  24. Brumback, R. A., & Weinberg, W. A. (1990). Pediatric behavioral neurology: An update on the neurologic aspects of depression, hyperactivity, and learning disabilities. Neurologic Clinics, 8, 677–703.... 3PubMedGoogle Scholar
  25. Biederman, J., Newcorn, J., & Sprich, S. E. (1991). Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry, 148, 564–577.... 3PubMedGoogle Scholar
  26. Accardo, P. J., Blondis, T. A., & Whitman, B. Y. (1990). Disorders of attention and activity level in a referral population. Pediatrics, 85, 426–431.... 3PubMedGoogle Scholar
  27. Abramowicz, M. (1990). Sudden death in children treated with a tricyclic antidepressant. The Medical Letter on Drugs and Therapeutics, 32, 53.... 3Google Scholar
  28. Abikoff, H. (1985). Efficacy of cognitive training interventions in hyperactive children: A critical review. Special Issue: Attention deficit disorder: Issues in assessment and intervention. Clinical Psychology Review, 5, 479–512.CrossRefGoogle Scholar
  29. Abikoff, H. (1991). Cognitive training in ADHD children: Less to it than meets the eye. Journal of Learning Disabilities, 24, 205–209.PubMedCrossRefGoogle Scholar
  30. Adelman, H. S., & Compas, B. E. (1977). Stimulant drugs and learning problems. Journal of Special Education, 11, 377–416.CrossRefGoogle Scholar
  31. American Psychiatric Association. (1968). Diagnostic and statistical manual for mental disorders (Second Edision). Washington, DC: Author.Google Scholar
  32. American Psychiatric Association. (1980). Diagnostic and statistical manual for mental disorders (Third Edition). Washington, DC: Author.Google Scholar
  33. American Psychiatric Association. (1987). Diagnostic and statistical manual for mental disorders (Third Edition-Revised). Washington, DC: Author.Google Scholar
  34. American Psychiatric Association (1994, work in progress). Diagnostic and statistical manual for mental disorders option books (Fourth Edition). Washington, DC: Author.Google Scholar
  35. Arnold, L. E. (1993). NIMH-funded research on ADHD. Proceedings from the CHADD Conference, San Diego, CA.Google Scholar
  36. Arnold, L. E., Huestis, R. D., Smeltzer, D. J., Scheib, J., Wemmer, D., & Coiner, G. (1976). Levoamphetamine versus dextroamphetamine minimal brain dysfunction. Archives of General Psychiatry, 23, 292–301.CrossRefGoogle Scholar
  37. Baldessarini, R. J. (1972). Behavior modification by drugs: I. Pharmacology of the amphetamines. Pediatrics, 49, 694–701.PubMedGoogle Scholar
  38. Barkley, R. A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18, 137–165.PubMedCrossRefGoogle Scholar
  39. Barkley, R. A. (1990). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford.Google Scholar
  40. Barkley, R. A., & Cunningham, C. E. (1978). Do stimulant drugs improve academic performance of hyperactive children? A review of outcome research. Clinical Pediatrics, 17, 85–92.PubMedCrossRefGoogle Scholar
  41. Barkley, R. A., Fischer, M, Edelbrock, C. S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria, I: An 8-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 546–557.PubMedCrossRefGoogle Scholar
  42. Barkley, R. A., Fischer, M., Newby, R. F., & Breen, M. (1988). Development of a multimethod clinical protocol for assessing stimulant medication drug response in children with attention deficit disorder. Journal of Clinical Child Psychology, 17, 14–24.CrossRefGoogle Scholar
  43. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic, placebo-controlled evaluation. Pediatrics, 86, 184–192.PubMedGoogle Scholar
  44. Bellamy, G. T. (1987). Education for the Handicapped Law Report, 211:242. Alexandria, Virginia: CCR Publishing.Google Scholar
  45. Biederman, J. (1988). Pharmacological treatment of adolescents with affective disorders and attention deficit disorders. Psychopharmacology Bulletin, 24, 81–87.PubMedGoogle Scholar
  46. Bloomingdale, L. M. (Ed.). (1984). Attention deficit disorder (Vol. 1): Diagnostic, cognitive, and therapeutic understanding. Jamaica, NY: Spectrum.Google Scholar
  47. Bloomingdale, L. M. (Ed.). (1985). Attention deficit disorder (Vol. 2): Identification, course, and rationale. Jamaica, NY: Spectrum.Google Scholar
  48. Bloomingdale, L. M. (Ed.). (1988). Attention deficit disorder (Vol. 3): New research in attention, treatment, and psychopharmacology. New York: Pergamon Press.Google Scholar
  49. Bloomingdale, L. M., & Sergeant, J. (Eds.). (1988). Attention deficit disorder (Vol. 5): Criteria, cognitive, and intervention. New York: Pergamon Press.Google Scholar
  50. Bloomingdale, L. M., & Swanson, J. M. (Eds.). (1989). Attention deficit disorder (Vol. 4): Current concepts and emerging trends in attentional and behavioral disorders of childhood. New York: Pergamon Press.Google Scholar
  51. Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577–585.Google Scholar
  52. Bradley, C. (1950). Benzedrine and dexedrine in the treatment of children’s behavior disorders. Pediatrics, 5, 24–37.PubMedGoogle Scholar
  53. Brecher, E. M. (1972). Licit and illicit drugs. New York: Consumer’s Union.Google Scholar
  54. Brown, G. L., Ebert, M. H., Mikkelsen, E. J., & Hunt, R. D. (1980). Behavior and motor activity response in hyperactive children and plasma amphetamine levels following a sustained release preparation. Journal of the American Academy of Child Psychiatry, 19, 225–239.PubMedCrossRefGoogle Scholar
  55. Brown, G. L., Hunt, R. D., Ebert, M. H., Bunney, W. E., & Kopin, I. J. (1979). Plasma levels of d-amphetamine in hyperactive children. Psychopharmacology, 62, 133–140.PubMedCrossRefGoogle Scholar
  56. Cantwell, D. P. (in press). Psychopharmacological treatment of ADD and related disorders: Current issues. Journal of Child and Adolescent Psychopharmacology. Google Scholar
  57. Carlsson, A. (1975). Receptor-mediated control of dopamine metabolism. In E. Usdin & J. W. Bunney (Eds.), Pre- and postsynaptic receptors. New York: Marcel Dekker.Google Scholar
  58. Chan, Y. M., Soldin, S. J., Swanson, J. M., Deber, C. M., Thiessen, J. J., & MacLeod, S. (1980). Gas chromatographic/mass spectroscopic analysis of methylphenidate (Ritalin) in serum. Clinical Biochemistry Journal, 13, 266–272.CrossRefGoogle Scholar
  59. Chan, Y. M., Swanson, J. M., Soldin, S. S., Thiessen, J. J., Macleod, S. M., & Logan, W. (1983). Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. Pediatrics, 72, 56–59.PubMedGoogle Scholar
  60. Chesapeake Institute, U.S. Department of Education. (1993). Proceedings of the forum on the education of children with attention deficit disorder. Washington, DC.Google Scholar
  61. Cohen, D. J., & Young, J. G. (1977). Neurochemistry and child psychiatry. Journal of the American Academy of Child Psychiatry, 16, 353–411.PubMedCrossRefGoogle Scholar
  62. Cole, J. (1969). The amphetamines in child psychiatry: A review. Seminars in Psychiatry, 1, 174–178.Google Scholar
  63. Collier, C. P., Soldin, S. J., Swanson, J. M, MacLeod, S. M., Weinberg, F., & Rochefort, J. G. (1985). Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Clinical Pharmacokinetics, 10, 269–278.PubMedCrossRefGoogle Scholar
  64. Conners, C. K. (1971). Recent drug studies. Journal of Learning Disabilities, 4, 476–483.CrossRefGoogle Scholar
  65. Conners, C. K., & Eisenberg, L. (1963). The effects of methylphenidate on symptomatology and learning in disturbed children. American Journal of Psychiatry, 120, 458–464.PubMedGoogle Scholar
  66. Conners, C. K., & Solanto, B. A. (1984). The psychophysiology of stimulant drug response in hyperkinetic children. In L. M. Bloomingdale (Ed.), Attention deficit disorder (Vol. 1): Diagnostic, cognitive, and therapeutic understanding (pp. 191–204). Jamaica, NY: Spectrum.Google Scholar
  67. Cooper, H. M. (1989). Integrating research: A guide for literature reviews, (Vol. 2). Newbury Park, CA: Sage.Google Scholar
  68. Cooper, J. R., Bloom, F. E., & Roth, R. H. (1986). The biochemical basis of neuropharmacology. New York: Oxford University Press.Google Scholar
  69. Cowart, V. S. (1988). The Ritalin controversy: What’s made this drug’s opponents hyperactive? Journal of the American Medical Association, 259, S-W.Google Scholar
  70. Coyle, J. T., & Snyder, S. H. (1969). Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas. Journal of Pharmacology and Experimental Therapeutics, 170, 221–231.PubMedGoogle Scholar
  71. Davila, R. R., Williams, M. L., & MacDonald, J. T. (1991). Clarification of policy to address the needs of children with attention deficit hyperactivity disorders within general and/or special education. Memorandum from the U.S. Department of Education: Office of Special Education and Rehabilitative Services.Google Scholar
  72. Douglas, V. I., Barr, R. G., Amin, K., O’Neill, M. E., & Britton, B. G. (1988). Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry, 29, 453–475.PubMedCrossRefGoogle Scholar
  73. Dykman, R. A., McGrew, J., Harris, T. S., Peters, J. E., & Ackerman, P. T. (1976). Two blinded studies of the effects of stimulant drugs on children: Pemoline, methylphenidate, and placebo. In R. P. Anderson & C. G. Halcomb (Eds.), Learning Disability/Minimal Brain Dysfunction Syndrome. Springfield, IL: Thomas.Google Scholar
  74. Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991). Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? Psychiatry Research, 36, 141–155.PubMedCrossRefGoogle Scholar
  75. Elia, J., & Rapoport, J. L. (1991). Ritalin versus dextroamphetamine in ADHD: Both should be tried. In L. L. Greenhill & B. B. Osman (Eds.), Ritalin: Theory and Patient Management (pp. 79–74). New York: Mary Ann Liebert, Publishers.Google Scholar
  76. Fish, B. (1971). The “one child, one drug” myth of stimulants in hyperkinesis. Archives of General Psychology, 25, 193–203.CrossRefGoogle Scholar
  77. Fisher, S. (1959). Child research in psychopharmacology. Springfield, IL: Thomas.Google Scholar
  78. Forness, S.R., Swanson, J. M., Cantwell, D. P., Guthrie, D., & Sena, R. (1992). Response to stimulant medication across six measures of school-related performance in children with ADHD and disruptive behavior. Behavioral Disorders, 18, 42–53.Google Scholar
  79. Forness, S. R., Swanson, J. M, Cantwell, D. P., Youpa, D., & Hanna, G. L. (1992). Stimulant medication and reading performance. Journal of Learning Disabilities, 25, 115–123.PubMedCrossRefGoogle Scholar
  80. Gadow, K. D. (1985). Relative efficacy of pharmacological, behavioral, and combination treatments for enhancing academic performance. Clinical Psychology Reviews, 5, 513–533.CrossRefGoogle Scholar
  81. Gadow, K. D. (1989). Dose response effects of stimulant drugs: A clarification of issues. In L. M. Bloomingdale & J. M. Swanson (Eds.), Attention deficit disorder: Current concepts and emerging trends in attentional and behavioral disorders of childhood (pp. 25–56). New York: Pergamon Press.Google Scholar
  82. Gittelman, R., & Kanner, A. (1986). Psychopharmacotherapy. In H. Quay & J. Werry (Eds.), Psychopathological disorders of childhood (pp. 455–495). New York: Wiley.Google Scholar
  83. Gilman, A., Goodman, L., Rall, T., & Murad, F. (Eds.). (1985). Goodman and Gilman’s The pharmacological basis of therapeutics (7th Edition). New York: Macmillan.Google Scholar
  84. Gordon, M. (1983). The Gordon Diagnostic System. DeWitt: Gordon Systems.Google Scholar
  85. Greenhill, L. L., & Osman, B. B. (Eds.). (1991). Methylphenidate in the clinical office practice of child psychiatry. In Ritalin: Theory and patient management (pp. 97–117). New York: Mary Ann Liebert, Publishers.Google Scholar
  86. Greenberg, L. L. (1991). TOVA Interpretation Manual. Minneapolis, MN: Author.Google Scholar
  87. Greenhill, L. L., & Osman, B. B. (Eds.). (1991). Ritalin: Theory and patient management. New York: Mary Ann Liebert, Publishers.Google Scholar
  88. Grinspoon, L., & Hedblom, P. (1975). The treatment of hyperkinetic children. In L. Grinspoon & P. Hedlom (Eds.), The speed culture: Amphetamine use and abuse in America (pp. 227–257). Cambridge, MA: Harvard University Press.Google Scholar
  89. Gualtieri, C. T., Wargin, W., Kanoy, R., Patrick, K., Shen, C. D., Youngblood, W., Mueller, R. A., & Breese, G. R. (1982). Clinical studies of methylphenidate serum levels in children and adults. Journal of the American Academy of Child Psychiatry, 21, 19–26.PubMedCrossRefGoogle Scholar
  90. Hauger, R. L., Angel, L. I., Janowsky, A., Berger, P., & Hulihan-Gilbin, B. (1990). Brain recognition sites for methylphenidate and amphetamines. In S. Deutsch, A. Weizman, & R. Weizman (Eds.), Application of basic neuroscience to child psychiatry (pp. 77–100). New York: Plenum Medical Book Company.CrossRefGoogle Scholar
  91. Hentoff, N. (1972, May 25). Drug pushing in the schools: The professionals (1). The Village Voice, pp. 20–22, 25.Google Scholar
  92. Hubbard, J. W., Srinivas, N. R., Quinn, D., & Midha, K. K. (1989). Enantioselective aspects of the disposition of d1-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder. Journal of Pharmaceutical Science, 78, 944r-947.CrossRefGoogle Scholar
  93. Hunt, R. D. (1987). Treatment effects of oral and transdermal Clonidine in relation to methylphenidate: An open pilot study in ADD-H. Psychopharmacology Bulletin, 23, 111–114.PubMedGoogle Scholar
  94. Journal of Child Neurology (1986-). Littleton, MA: PSG Publishing Co. Journal of Learning Disabilities (1968-). Austin, TX: Donald D. Hammill Foundation.Google Scholar
  95. Kavale, K. (1982). The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis. Journal of Learning Disabilities, 15, 280–289.PubMedCrossRefGoogle Scholar
  96. Kavanagh, J. F., & Truss, T. J., Jr. (Eds.). (1988). Learning disabilities: Proceedings of the national conference. Parkton, MD: York Press.Google Scholar
  97. Kohn, A. (1989). Suffer the restless children. The Atlantic Monthly, 264, 90–98.Google Scholar
  98. Kupietz, S. S. (1991). Ritalin blood levels and their correlations with measures of learning. In L. L. Greenhill & B. B. Osman (Eds.), Ritalin: Theory and patient management (pp. 247–256). New York: Mary Ann Liebert, Publishers.Google Scholar
  99. Laufer, M. W., & Denhoff, E. (1957). Hyperkinetic behavior syndrome in children. Journal of Pediatrics, 50, 463–474.PubMedCrossRefGoogle Scholar
  100. Lipman, R. S. (1974). NIMH-PRB support of research in minimal brain dysfunction in children. In C. K. Conners (Ed.), Clinical use of stimulant drugs in children (pp. 203–213). Amsterdam: Excerpta Medica.Google Scholar
  101. Loney, J., & Milich, R. (1982). Hyperactivity, inattention, and aggression in clinical practice. Advances in Developmental and Behavioral Pediatrics, 3, 113–147.Google Scholar
  102. Lou, H, Henriksen, L., & Bruhn, P. (1984). Focal hypoperfusion in children with dysphasia and/or attention deficit disorder. Archives of Neurology, 41, 825–829.PubMedCrossRefGoogle Scholar
  103. Malone, M. A., Kershner, J. R., & Swanson, J. M. (1994). Hemispheric processing and methyl-phenidate effects in attention-deficit hyperactivity disorder. Journal of Child Neurology, 9, 1–8.CrossRefGoogle Scholar
  104. McCracken, J. T. (1991). A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. Journal of Neuropsychiatry Clinical Neuroscience, 3, 201–209.Google Scholar
  105. McGuinness, D. (1989). Attention deficit disorder: The emperor’s clothes, animal “pharm,” and other fiction. In S. Fisher & R. P. Greenberg (Eds.), The limits of biological treatments of psychological distress (pp. 151–187). Hillsdale, NJ: Erlbaum.Google Scholar
  106. McMillen, B. A. (1983). CNS stimulants: Two distinct mechanisms of action for amphetamine-like drugs. Trends in Pharmacological Science, 19, 429–432.CrossRefGoogle Scholar
  107. Millichap, J. G. (1973). Drugs in management of minimal brain dysfunction. Annuals of the New York Academy of Sciences, 205, 321–334.CrossRefGoogle Scholar
  108. Morrison, R. T., & Boyd, R. N. (1987). Organic chemistry (5th ed.). Boston: Allyn & Bacon.Google Scholar
  109. Ottenbacher, K. J., & Cooper, M. M. (1983). Drug treatment of hyperactivity in children. Developmental Medicine and Child Neurology, 25, 358–366.PubMedCrossRefGoogle Scholar
  110. Parker, H. C. (1992). The ADD Hyperactivity Handbook for School. Plantation, FL: Impact Publications.Google Scholar
  111. Patrick, K. S., Mueller, R. A., Gualtieri, C. T., & Breese, G. R. (1987). Pharmacokinetics and actions of methylphenidate. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress. New York: Raven.Google Scholar
  112. Pelham, W. E., & Bender, M. E. (1982). Peer relationships in hyperactive children: Description and treatment. Advances in learning and behavioral disabilities, (vol. 1, pp. 365–436). Greenwich, CT: JAI Press.Google Scholar
  113. Pelham, W. E., Bender, M. E., Cadell, J., Booth, S., & Moorer, S. H. (1985). The dose-response effects of methylphenidate on classroom academic and social behavior in children with attention deficit disorder. Archives of General Psychiatry, 42, 948–952.PubMedCrossRefGoogle Scholar
  114. Pelham, W. E., Jr., Greenslade, K. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthries, K. J., Hoover, M. D., & Dahl, R. E. (1990). The efficacy of long-acting stimulants on ADHD children: A comparison of standard methylphenidate, Ritalin-SR, Dexedrene Spansule, and Pemoline. Pediatrics, 86, 226–237.PubMedGoogle Scholar
  115. Pelham, W. E., & Murphy, H. A. (1986). Attention deficit and conduct disorders. In M. Hersen (Ed.), Pharmacological and behavioral treatments: An integrative approach (pp. 108–148). New York: Wiley.Google Scholar
  116. Pelham, W. E., Sturges, J., Hoza, J., Schmidt, C., Bijlsma, J. J., Milich, R., & Moorer, S. (1987). Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit hyperactivity disorder. Pediatrics, 80, 491–501.PubMedGoogle Scholar
  117. Professional Group for Attention and Related Disorders. (1990). Submission to the U.S. Department of Education. Notice of Inquiry on ADD. Physician’s Desk Reference (44th Ed.). (1990). Oradell, NJ: Barnhart.Google Scholar
  118. Porrino, L. J., & Lucignani, G. (1987). Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate: Relevance to its action in hyperactive children. Biological Psychiatry, 22, 126–138.PubMedCrossRefGoogle Scholar
  119. Porrino, L. J., Lucignani, G., Dow-Edwards, D., & Sokoloff, L. (1984). Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Research, 307, 311–320.PubMedCrossRefGoogle Scholar
  120. Rapoport, J. L., Buchsbaum, M., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelson, E. J. (1978). Detroamphetamine: Cognitive and behavioral effects on normal prepubertal boys. Science, 199, 560–563.PubMedCrossRefGoogle Scholar
  121. Rapport, M. D., DuPaul, G. J., & Kelly, K. L. (1989). Attention deficit hyperactivity disorder and methylphenidate: The relationship between gross body weight and drug response in children. Psychopharmacology Bulletin, 25, 285–290.PubMedGoogle Scholar
  122. Rapport, M. D., DuPaul, G. J., Stoner, G., & Jones, J. T. (1986). Comparing classroom and clinic measures of attention deficit disorder: Differential, idiosyncratic, and dose-response effects of methylphenidate. Journal of Consulting and Clinical Psychology, 54, 334–341.PubMedCrossRefGoogle Scholar
  123. Rapport, M. D., & Kelly, K. L. (1991). Psychostimulant effects on learning and cognitive function: Findings and implications for children with attention deficit hyperactivity disorder. Clinical Psychology Review, 11, 61–92.CrossRefGoogle Scholar
  124. Rapport, M. D., Stoner, G., DuPaul, G. J., Birmingham, B. K., & Tucker, S. (1985). Methylphenidate in hyperactive children: Differential effects of dose on academic, learning, and social behavior. Journal of Abnormal Child Psychology, 13, 227–244.PubMedCrossRefGoogle Scholar
  125. Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256–2258.PubMedCrossRefGoogle Scholar
  126. Schräg, P., & Divoky, D. (1975). The myth of the hyperactive child and other means of child control New York: Pantheon.Google Scholar
  127. Shaywitz, S. E., Hunt, R. D., Jatlow, P., Cohen, D. J., Young, J. G., Pierce, R. N., Anderson, G. M., & Shaywitz, B. A. (1982). Psychopharmacology of attention deficit disorder: Pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate. Pediatrics, 69, 688–694.PubMedGoogle Scholar
  128. Shaywitz, S. E., & Shaywitz, B. A. (1988). Attention deficit disorder: Current perspectives. In J. F. Kavanaugh & T. J. Truss (Eds.), Learning Disabilities: Proceedings of the national conference (pp. 369–523). New York: Maple Press.Google Scholar
  129. Shaywitz, B. A., Yager, R. D., & Klopper, J. H. (1976). Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction. Science, 191, 305–308.PubMedCrossRefGoogle Scholar
  130. Sleator, E. K., & von Neuman, A. W. (1974). Methylphenidate in the treatment of hyperkinetic children: Recommendations on diagnosis, dosage, and monitoring. Clinical Pediatrics, 13, 19–24.PubMedCrossRefGoogle Scholar
  131. Smith, S. E., & Wesson, D. R. (Eds.). (1973). Uppers and downers. Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
  132. Snyder, S. H., & Meyerhoff, J. L. (1973). How amphetamine acts in minimal brain dysfunction. Annals of the New York Academy of Sciences, 205, 310–320.PubMedCrossRefGoogle Scholar
  133. Solanto, M. V. (1986). Behavioral effects of low-dose methylphenidate in childhood attention deficit disorder: Implications for a mechanism of stimulant drug action. Journal of the American Academy of Child Psychiatry, 25, 96–101.PubMedCrossRefGoogle Scholar
  134. Sprague, R. L., & Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Difference in dose effects on learning and social behavior. Science, 198, 1274–1276.PubMedCrossRefGoogle Scholar
  135. Srinivas, N. R., Hubbard, J. W., Quinn, D., & Midah, K. K. (1992). Enantioselective pharmo-kinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clinical Pharmacological Therapy, 52, 561–568.CrossRefGoogle Scholar
  136. Srinivas, N. R., Quinn, D., Hubbard, J. W., & Midha, K. K. (1987). Stereoselective disposition of methylphenidate in children with Attention Deficit Hyperactivity Disorder. Journal of Pharmacology and Experimental Therapy, 241, 300–306.Google Scholar
  137. Sroufe, L. A., & Stewart, M. A. (1973). Treating problem children with stimulant drugs. New England Journal of Medicine, 289, 407–413.PubMedCrossRefGoogle Scholar
  138. Swanson, J. M. (1985). Measures of cognitive functioning appropriate for use in pediatric psychopharmacological research studies. Psychopharmacological Bulletin, 21, 887–890.Google Scholar
  139. Swanson, J. M. (1988). What do psychopharmacological studies tell us about information processing deficits in ADDH? In L. M. Bloomingdale & J. Sergeant (Eds.), Attention deficit disorder: Criteria, cognition, intervention (pp. 97–116). New York: Pergamon Press.Google Scholar
  140. Swanson, J. M. (1989). Paired-associate learning in the assessment of ADDH children. In L. M. Bloomingdale & J. M. Swanson (Eds.), Attention Deficit Disorder: Volume IV: Emerging trends in attentional and behavioral disorders of childhood (pp. 87–124). New York: Pergamon Press.Google Scholar
  141. Swanson, J. M. (1992). School-based assessments and interventions for ADD students. Irvine, CA: K.C. Publishing.Google Scholar
  142. Swanson, J. M., & Cantwell, D. (1989). Dose-related effects of methylphenidate on stimulus encoding and memory comparison times in ADHD children. Paper presented at The Meeting of the American Academy of Child and Adolescent Psychiatry, New York.Google Scholar
  143. Swanson, J. M., Cantwell, D., Lerner, M., McBurnett, K., & Hanna, G. (1991). Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities, 24, 219–320.PubMedCrossRefGoogle Scholar
  144. Swanson, J. M., & Kinsbourne, M. (1976). Stimulant-related state-dependent learning in hyperactive children. Science, 192, 1354–1356.PubMedCrossRefGoogle Scholar
  145. Swanson, J. M., & Kinsbourne, M. (1979). The cognitive effects of stimulant drugs on hyperactive (inattentive) children. In G. Hale & M. Lewis (Eds.), Attention and the development of cognitive skills (pp. 249–274). New York: Plenum Press.CrossRefGoogle Scholar
  146. Swanson, J. M., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). A time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21–29.PubMedGoogle Scholar
  147. Swanson, J. M., Kurland, L., Weinberg, F., & Kinsbourne, M. (1978). Comparing the behavioral effectiveness of two drugs which have different half lives. Pediatric Research, 12, 376.CrossRefGoogle Scholar
  148. Swanson, J. M., McBurnett, K., Wigal, T., Pnffner, L. J., Lerner, M. A., Williams, L., Christian, D. L., Tamm, L., Willcut, E., Crowley, K., Clevenger, W., Khouzam, N., Woo, C., Crinella, F. M., Fisher, T. D. (1993). Effect of stimulant medication on children with Attention Deficit Disorder: A “review of reviews.” Exceptional Children, 60, 154–162.Google Scholar
  149. Swanson, J. M., Sandman, C. A., Deutsch, C., & Baren, M. (1983). Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive and electrophysiologic effects. Pediatrics, 72, 49–55.PubMedGoogle Scholar
  150. Swanson, J. M., Shea, C., McBurnett, K., Potkin, S. G., Fiore, T., & Crinella, F. M. (1990). Attention and hyperactivity. In J. Enns (Ed.), The development of attention: Research and theory. New York: Elsevier.Google Scholar
  151. Tannock, R., Schachar, R. J., Carr, R. P., Chajczyk, D., & Logan, G. D. (1989). Effects of methylphenidate on inhibitory control in hyperactive children. Journal of Abnormal Child Psychology, 17, 473–491.PubMedCrossRefGoogle Scholar
  152. Tannock, R., Schachar, R. J., Carr, R. P., & Logan, G. D. (1989). Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children. Pediatrics, 84, 648–657.PubMedGoogle Scholar
  153. Taylor, E. A. (1983). Drug response and diagnostic validation. In M. Rutter (Ed.), Developmental neuropsychiatry (pp. 348–368). New York; Guilford.Google Scholar
  154. Thurber, S., & Walker, C. A. (1983). Medication and hyperactivity: A meta-analysis. The Journal of General Psychology, 108, 79–86.PubMedCrossRefGoogle Scholar
  155. Ullmann, R. K., & Sleator, E. K. (1986). Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation. Clinical Pediatrics, 25, 594–599.PubMedCrossRefGoogle Scholar
  156. Weiss, B., & Laties, V. G. (1963). Enhancement of human performance by caffeine and the amphetamines. Psychological Review, 14, 1–36.CrossRefGoogle Scholar
  157. Wender, P. H. (1971). Minimal brain dysfunction in children. New York: Wiley-Interscience.Google Scholar
  158. Wender, P. H. (1973). Some speculations concerning a possible biochemical basis of minimal brain dysfunction. In F. F. De La Cruz, B. H. Fox, R. H. Roberts, & G. Tarjan (Eds.), Minimal brain dysfunction in children (pp. 18–28). New York: Wiley-Interscience.Google Scholar
  159. Werry, J. S., Aman, M. G., & Diamond, E. (1980). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27–35.PubMedCrossRefGoogle Scholar
  160. Whalen, C. K., & Henker, B. (1976). Psychostimulants and children: A review and analysis of drug effectiveness. Psychological Bulletin, 83, 1113–1130.PubMedCrossRefGoogle Scholar
  161. Whalen, C. K., & Henker, B. (1991). Therapies for hyperactive children: Comparisons, combinations, and compromises. Journal of Consulting and Clinical Psychology, 59, 126–137.PubMedCrossRefGoogle Scholar
  162. Zametkin, A. J., & Rapoport, J. L. (1987). Noradrenergic hypothesis of attention deficit disorder with hyperactivity: A critical review. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 837–842). New York: Raven.Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • James M. Swanson
    • 1
  • Keith McBurnett
    • 1
  • Diane L. Christian
    • 1
  • Tim Wigal
    • 1
  1. 1.Department of Pediatrics, Child Development CenterUniversity of California at IrvineIrvineUSA

Personalised recommendations